InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Watson W. Mark, Director. Director active across 3 companies, notably Vaxart, Inc.. In total, 11 disclosures have been published. Total volume traded: €11k. The latest transaction was filed on 17 November 2025 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
US$5,29515,000 shares@ US$0.3530.0032% mcap100.0% of flow
Common Stock
SEC:0001437749-25-037051·
Ideal exit: 14 Aug 2026 (T+270)
€5,29515,000 shares@ €0.3530.0032% mcap50.0% of flow
Common Stock
SEC:0001437749-25-037051:0·
Ideal exit: 14 Aug 2026 (T+270)
090,663 shares0
Common Stock
SEC:0001103021-22-000075:0·
07,684 shares0
Common Stock
SEC:0001103021-22-000025·
07,684 shares0
Common Stock
SEC:0001103021-22-000025:0·
013,491 shares0
Common Stock
SEC:0001127602-21-024398·
013,491 shares0
Common Stock
SEC:0001127602-21-024398:0·
030,000 shares0
Common Stock
SEC:0001103021-21-000074·
030,000 shares0
Common Stock
SEC:0001103021-21-000074:0·
€23,620694 shares@ €34.0347100.0% of flow
Common Stock
SEC:0001127602-21-017319·
€23,620694 shares@ €34.034750.0% of flow
Common Stock
SEC:0001127602-21-017319:0·
11 of 11 declarations
About Watson W. Mark
Mark Watson is a Director at Vaxart, Inc., SYKES ENTERPRISES INC, and BIODELIVERY SCIENCES INTERNATIONAL INC. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. His diverse experience is valuable in guiding these organizations towards their objectives.
